{"filing":{"accession_number":"0001683168-26-004975","cik":"0001367083","ticker":"SNOA","company_name":"Sonoma Pharmaceuticals, Inc.","form":"8-K","filing_date":"2026-06-18","report_date":null,"primary_document":"sonoma_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316826004975/sonoma_8k.htm"},"events":[{"id":11917,"run_id":10488,"accession_number":"0001683168-26-004975","anchor_item_number":"8.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"The filing discloses an At Market Issuance Sales Agreement (ATM) under which Sonoma Pharmaceuticals may offer and sell shares of common stock through an agent. The company has already sold 173,073 shares for $574,633 and increased the aggregate offering price to $3,641,703 as of the filing date. ATM offerings are classic dilutive equity issuances that signal capital-raising activity and potential shareholder dilution, material to investors assessing ownership stakes and capital structure.","company_name":"Sonoma Pharmaceuticals, Inc.","ticker":"SNOA","filing_date":"2026-06-18","form":"8-K","submitted_at":null,"items":[{"id":8631,"accession_number":"0001683168-26-004975","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"The filing discloses an At Market Issuance Sales Agreement (ATM) under which Sonoma Pharmaceuticals may offer and sell shares of common stock through an agent. The company has already sold 173,073 shares for $574,633 and increased the aggregate offering price to $3,641,703 as of the filing date. ATM offerings are classic dilutive equity issuances that signal capital-raising activity and potential shareholder dilution, material to investors assessing ownership stakes and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:35:23.142629+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8631,"accession_number":"0001683168-26-004975","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"The filing discloses an At Market Issuance Sales Agreement (ATM) under which Sonoma Pharmaceuticals may offer and sell shares of common stock through an agent. The company has already sold 173,073 shares for $574,633 and increased the aggregate offering price to $3,641,703 as of the filing date. ATM offerings are classic dilutive equity issuances that signal capital-raising activity and potential shareholder dilution, material to investors assessing ownership stakes and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:35:23.142629+00:00","company_name":"Sonoma Pharmaceuticals, Inc.","ticker":"SNOA","filing_date":"2026-06-18"}]}